Heart failure & cardiomyopathiesRandomised controlled trial
Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study
- Randomised controlled trial
- early termination (COVID-19 pandemic)
- Study terminated early due to the COVID-19 pandemic; underpowered
Authors' conclusion
The study does not support the notion that comprehensive RM, when compared to standard RM, in HF patients with CRT improves the clinical outcome of all-cause mortality or WHF hospitalizations.
Study context
- Population
- Heart failure (HF) patients with cardiac resynchronization therapy (CRT) devices
- Participants
- 652 patients
- Comparison
- Comprehensive remote monitoring (RM) vs standard RM of CRT devices
- Primary endpoint
- All-cause mortality or hospitalization for worsening HF
- Follow-up
- Mean 18 ± 8 months
Primary result
As reported in the abstract
P = 0.13
Secondary outcomes
Improvement of quality of life vs baseline (MLHF questionnaire)
P = 0.03
Original publication
Comprehensive vs. standard remote monitoring of cardiac resynchronization devices in heart failure patients: results of the ECOST-CRT study. Europace. Published 14 October 2024. doi:10.1093/europace/euae233
Summarised from the published abstract; every number is checked against it